Karen S Anderson Selected Research

AZD4547

1/2019

The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karen S Anderson Research Topics

Disease

62	Neoplasms (Cancer) 01/2024 - 06/2003
26	Breast Neoplasms (Breast Cancer) 01/2024 - 04/2008
16	Infections 04/2024 - 05/2003
10	Acquired Immunodeficiency Syndrome (AIDS) 10/2020 - 04/2002
7	COVID-19 04/2024 - 08/2020
7	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 03/2009
6	Oropharyngeal Neoplasms 02/2018 - 07/2015
6	HIV Infections (HIV Infection) 01/2017 - 02/2004
4	Squamous Cell Carcinoma of Head and Neck 01/2023 - 11/2018
4	Triple Negative Breast Neoplasms 11/2017 - 02/2011
4	Malaria 09/2014 - 02/2008
3	Disease Progression 03/2024 - 06/2015
3	Drug-Related Side Effects and Adverse Reactions 01/2019 - 05/2010
3	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2007
3	Carcinogenesis 12/2017 - 02/2004
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2013 - 05/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 06/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2020 - 01/2016
2	Melanoma (Melanoma, Malignant) 05/2020 - 02/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2019 - 10/2018
2	Carcinoma (Carcinomatosis) 06/2015 - 02/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2015 - 06/2012
2	Human Influenza (Influenza) 06/2011 - 06/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2023
1	Rare Diseases (Rare Disease) 12/2022
1	Cholangiocarcinoma 10/2022
1	Hot Flashes 05/2020
1	Residual Neoplasm 01/2019

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2005
20	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
18	AntigensIBA 01/2024 - 06/2003
13	AutoantibodiesIBA 01/2024 - 04/2008
13	AntibodiesIBA 01/2021 - 07/2005
10	EnzymesIBA 10/2018 - 11/2003
9	VaccinesIBA 11/2023 - 07/2005
9	Neoplasm Antigens (Tumor Antigens)IBA 01/2017 - 07/2005
8	Peptides (Polypeptides)IBA 01/2022 - 02/2004
8	EpitopesIBA 03/2019 - 09/2010
8	NucleosidesIBA 01/2019 - 06/2009
7	Antiviral Agents (Antivirals)IBA 04/2024 - 07/2014
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2005
7	Immunoglobulin G (IgG)IBA 01/2021 - 01/2011
7	Reverse Transcriptase InhibitorsIBA 01/2019 - 06/2009
6	Estrogen ReceptorsIBA 05/2020 - 02/2011
5	Phosphotransferases (Kinase)IBA 05/2015 - 03/2007
5	thymidylate synthase-dihydrofolate reductaseIBA 02/2014 - 02/2008
4	Complement System Proteins (Complement)IBA 01/2024 - 01/2020
4	NucleotidesIBA 12/2014 - 02/2008
3	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2016
3	OligonucleotidesIBA 01/2022 - 09/2015
3	Peptide Hydrolases (Proteases)FDA Link 03/2021 - 08/2020
3	DNA Polymerase gammaIBA 01/2019 - 05/2010
3	N 30IBA 01/2018 - 03/2010
3	AutoantigensIBA 01/2017 - 02/2004
3	Gefitinib (Iressa)FDA Link 04/2015 - 03/2007
3	Folic Acid (Vitamin M)FDA LinkGeneric 09/2014 - 01/2009
3	Thymidylate SynthaseIBA 09/2014 - 10/2013
3	HLA-A*02:01 antigenIBA 06/2011 - 06/2003
2	Capecitabine (Xeloda)FDA Link 01/2024 - 09/2023
2	Gemcitabine FDA Link 01/2024 - 09/2023
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 09/2022 - 05/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2022 - 08/2005
2	CytidineIBA 01/2022 - 10/2018
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 12/2017
2	Cancer VaccinesIBA 12/2018 - 05/2009
2	CytosineIBA 10/2018 - 07/2002
2	InterferonsIBA 10/2018 - 03/2009
2	Oncogene Proteins (Oncogene Protein)IBA 12/2017 - 09/2010
2	Human immunodeficiency virus 1 reverse transcriptaseIBA 01/2017 - 08/2010
2	Mitochondrial DNA (mtDNA)IBA 01/2016 - 06/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2015 - 03/2007
2	Tenofovir (Viread)FDA Link 12/2014 - 08/2012
2	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 09/2014 - 10/2013
2	Immunodominant EpitopesIBA 08/2014 - 06/2003
2	LigandsIBA 08/2014 - 02/2011
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2014 - 12/2007
2	Antiparasitic Agents (Antiparasitics)IBA 10/2013 - 09/2013
2	Viral AntigensIBA 06/2011 - 06/2003
2	IntegrinsIBA 04/2011 - 02/2011
1	nirmatrelvir and ritonavir drug combinationIBA 04/2024
1	OsteopontinIBA 01/2024
1	TNF Receptor-Associated Factor 3IBA 01/2023
1	Estrogen Receptor alphaIBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 12/2022
1	Dual Specificity Phosphatase 1IBA 12/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2022
1	Drug CombinationsIBA 01/2022
1	perampanelIBA 03/2021
1	Azacitidine (5 Azacytidine)FDA Link 12/2020
1	MethyltransferasesIBA 05/2020
1	Acetates (Acetic Acid Esters)FDA Link 05/2020
1	Estrogens (Estrogen)FDA Link 05/2020
1	Papillomavirus Vaccines (HPV Vaccines)IBA 12/2019
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 01/2019

Therapy/Procedure

25	Therapeutics 01/2024 - 11/2003
8	Immunotherapy 03/2019 - 06/2003
4	Drug Therapy (Chemotherapy) 09/2022 - 08/2005
3	Highly Active Antiretroviral Therapy (HAART) 10/2020 - 07/2008
2	Neoadjuvant Therapy 01/2019 - 12/2017
1	Radiotherapy 09/2022